找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Legal Developments on Cybersecurity and Related Fields; Francisco António Carneiro Pacheco de Andrade,Pedr Book 2024 The Editor(s) (if app

[復(fù)制鏈接]
樓主: 無感覺
11#
發(fā)表于 2025-3-23 09:58:41 | 只看該作者
e towards the religious ‘other’.?The authors thus adopt this framework in the book, as a method of categorising people in a diverse society which in turnhelps readers to understand the nuances of Islam and Muslims in a huge country like Indonesia..978-981-97-1142-0978-981-97-1140-6Series ISSN 2522-8730 Series E-ISSN 2522-8749
12#
發(fā)表于 2025-3-23 16:09:11 | 只看該作者
13#
發(fā)表于 2025-3-23 21:41:45 | 只看該作者
Alessandra Silveirae towards the religious ‘other’.?The authors thus adopt this framework in the book, as a method of categorising people in a diverse society which in turnhelps readers to understand the nuances of Islam and Muslims in a huge country like Indonesia..978-981-97-1142-0978-981-97-1140-6Series ISSN 2522-8730 Series E-ISSN 2522-8749
14#
發(fā)表于 2025-3-24 02:08:33 | 只看該作者
15#
發(fā)表于 2025-3-24 02:51:46 | 只看該作者
Pedro Miguel Fernandes Freitasn evolution towards more aggressive histology, mostly diffuse large B-cell lymphoma (DLBCL) occurs in around 10% of cases. Since prospective phase III trials are lacking, the treatment is not standardised. Currently, the aim of treatment is primarily palliative, and outside of a clinical study, it i
16#
發(fā)表于 2025-3-24 09:21:51 | 只看該作者
17#
發(fā)表于 2025-3-24 14:26:13 | 只看該作者
Arno R. Lodder,Joeri J. Toetn evolution towards more aggressive histology, mostly diffuse large B-cell lymphoma (DLBCL) occurs in around 10% of cases. Since prospective phase III trials are lacking, the treatment is not standardised. Currently, the aim of treatment is primarily palliative, and outside of a clinical study, it i
18#
發(fā)表于 2025-3-24 15:58:59 | 只看該作者
Almudena Vali?o Cesrige Exposition gegenüber neuen Substanzen ausschlaggebend für die Wahl der Behandlung. Bruton-Tyrosinkinase(BTK)-Inhibitoren und der BCL2(?B-cell lymphoma 2“)-Inhibitor allein oder in Kombination mit Rituximab k?nnen in dieser Situation als optimale Therapie für die Mehrzahl der Patienten angesehen
19#
發(fā)表于 2025-3-24 21:30:46 | 只看該作者
20#
發(fā)表于 2025-3-25 00:55:00 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-10 00:07
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
新巴尔虎右旗| 南通市| 临桂县| 南开区| 巴彦淖尔市| 从江县| 渝北区| 武清区| 塘沽区| 洛浦县| 通渭县| 尉氏县| 邯郸市| 夏津县| 荔波县| 深水埗区| 布尔津县| 德庆县| 台山市| 屯门区| 台中县| 兴安县| 阳山县| 云梦县| 九寨沟县| 富蕴县| 洮南市| 阜平县| 莲花县| 嘉禾县| 惠来县| 文登市| 固镇县| 安化县| 岳西县| 浏阳市| 石渠县| 凤凰县| 大田县| 从化市| 建宁县|